BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  BioCapital

  3 Risky Biotech Stocks to Avoid Like the Plague

  October 28, 2016

   · 

  3 min read
• 

  Policy

  Deficiencies Found at Manufacturing Site Could Delay Approval of Sanofi Genzyme’s Next Blockbuster

  October 28, 2016

   · 

  2 min read
• 

  Deals

  Meet the 31-Year Old Man Behind This Year’s Biggest Biotech IPO

  October 28, 2016

   · 

  3 min read
• 

  Business

  Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas

  October 28, 2016

   · 

  2 min read
• Pharm Country

  University of Pennsylvania Study Looks To Speed Transplants With Hepatitis C-Infected Kidneys

  October 28, 2016

   · 

  1 min read
• Biotech Bay

  BioBeats Evolves From Stress App To Measurer Of Well-Being

  October 28, 2016

   · 

  1 min read
• Genetown

  These Pricey Cholesterol Drugs Aren’t Selling. And That Has The Biotech Industry Sweating

  October 28, 2016

   · 

  1 min read
• Biotech Bay

  Bristol-Myers Squibb CEO: “I Feel Really Good About Where We Are Going”

  October 28, 2016

   · 

  1 min read
• Business

  Pharma Bro Martin Shkreli Lunches With the Financial Times, Remains Unapologetic

  October 28, 2016

   · 

  1 min read
• Policy

  Despite Controversies, China Follows Same Bioethical Regulations As The West

  October 28, 2016

   · 

  1 min read